These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 16920047)

  • 21. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation.
    Büning C; Genschel J; Bühner S; Krüger S; Kling K; Dignass A; Baier P; Bochow B; Ockenga J; Schmidt HH; Lochs H
    Aliment Pharmacol Ther; 2004 May; 19(10):1073-8. PubMed ID: 15142196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
    Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
    Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease.
    Weiss B; Shamir R; Bujanover Y; Waterman M; Hartman C; Fradkin A; Berkowitz D; Weintraub I; Eliakim R; Karban A
    J Pediatr; 2004 Aug; 145(2):208-12. PubMed ID: 15289769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the CARD15 variants R702W, G908R and L1007fs in Italian IBD patients.
    Giachino D; van Duist MM; Regazzoni S; Gregori D; Bardessono M; Salacone P; Scaglione N; Sostegni R; Sapone N; Bresso F; Sambataro A; Gaia E; Pera A; Astegiano M; De Marchi M
    Eur J Hum Genet; 2004 Mar; 12(3):206-12. PubMed ID: 14747834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease.
    Laukens D; Peeters H; Marichal D; Vander Cruyssen B; Mielants H; Elewaut D; Demetter P; Cuvelier C; Van Den Berghe M; Rottiers P; Veys EM; Remaut E; Steidler L; De Keyser F; De Vos M
    Ann Rheum Dis; 2005 Jun; 64(6):930-5. PubMed ID: 15539413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of association between IBD5 and Crohn's disease in Japanese patients demonstrates population-specific differences in inflammatory bowel disease.
    Tosa M; Negoro K; Kinouchi Y; Abe H; Nomura E; Takagi S; Aihara H; Oomori S; Sugimura M; Takahashi K; Hiwatashi N; Takahashi S; Shimosegawa T
    Scand J Gastroenterol; 2006 Jan; 41(1):48-53. PubMed ID: 16373276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
    Pierik M; Vermeire S; Steen KV; Joossens S; Claessens G; Vlietinck R; Rutgeerts P
    Aliment Pharmacol Ther; 2004 Aug; 20(3):303-10. PubMed ID: 15274667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Haptoglobin polymorphism in patients with inflammatory bowel diseases].
    Papp M; Lakatos PL; ; Palatka K; Földi I; Udvardy M; Hársfalvi J; Tornai I; Vitális Z; Dinya T; Kovács A; Molnár T; Demeter P; Papp J; Lakatos L; Altorjay I
    Orv Hetil; 2006 Sep; 147(36):1745-50. PubMed ID: 17087019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CARD15 mutations in patients with Crohn's disease in a homogeneous Spanish population.
    Núñez C; Barreiro M; Domínguez-Muñoz JE; Lorenzo A; Zapata C; Peña AS
    Am J Gastroenterol; 2004 Mar; 99(3):450-6. PubMed ID: 15056084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DLG5 variants in inflammatory bowel disease.
    Büning C; Geerdts L; Fiedler T; Gentz E; Pitre G; Reuter W; Luck W; Buhner S; Molnar T; Nagy F; Lonovics J; Dignass A; Landt O; Nickel R; Genschel J; Lochs H; Schmidt HH; Witt H
    Am J Gastroenterol; 2006 Apr; 101(4):786-92. PubMed ID: 16494592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
    Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease.
    Oostenbrug LE; Dijkstra G; Nolte IM; van Dullemen HM; Oosterom E; Faber KN; de Jong DJ; van der Linde K; te Meerman GJ; van der Steege G; Kleibeuker JH; Jansen PL
    Scand J Gastroenterol; 2006 Oct; 41(10):1174-82. PubMed ID: 16990202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Granulomatous rosacea and Crohn's disease in a patient homozygous for the Crohn-associated NOD2/CARD15 polymorphism R702W.
    van Steensel MA; Badeloe S; Winnepenninckx V; Vreeburg M; Steijlen PM; van Geel M
    Exp Dermatol; 2008 Dec; 17(12):1057-8. PubMed ID: 18616576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
    Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
    Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined type-1 plasminogen activator inhibitor and NOD2/CARD15 genotyping predicts complicated Crohn's disease behaviour.
    Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Piu J; Reverter JC; Pique JM; Yagüe J; Panés J
    Aliment Pharmacol Ther; 2007 Feb; 25(4):429-40. PubMed ID: 17269998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hla-B genotype in Japanese patients with Crohn's disease.
    Kinouchi Y; Matsumoto K; Negoro K; Takagi S; Takahashi S; Hiwatashi N; Shimosegawa T
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S10-4. PubMed ID: 14530653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studies.
    Corleto VD; Pagnini C; Margagnoni G; Guagnozzi D; Torre MS; Martorelli M; Latiano A; Annese V; Caprilli R; Delle Fave G
    Dig Liver Dis; 2010 Mar; 42(3):179-84. PubMed ID: 19643686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of NOD2/CARD15 mutations in Malaysian patients with Crohn's disease.
    Chua KH; Hilmi I; Ng CC; Eng TL; Palaniappan S; Lee WS; Goh KL
    J Dig Dis; 2009 May; 10(2):124-30. PubMed ID: 19426395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A population-based case-control study of CARD15 and other risk factors in Crohn's disease and ulcerative colitis.
    Brant SR; Wang MH; Rawsthorne P; Sargent M; Datta LW; Nouvet F; Shugart YY; Bernstein CN
    Am J Gastroenterol; 2007 Feb; 102(2):313-23. PubMed ID: 17100976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. rs224136 on chromosome 10q21.1 and variants in PHOX2B, NCF4, and FAM92B are not major genetic risk factors for susceptibility to Crohn's disease in the German population.
    Glas J; Seiderer J; Pasciuto G; Tillack C; Diegelmann J; Pfennig S; Konrad A; Schmechel S; Wetzke M; Török HP; Stallhofer J; Jürgens M; Griga T; Klein W; Epplen JT; Schiemann U; Mussack T; Lohse P; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Mar; 104(3):665-72. PubMed ID: 19262523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.